Integer (NYSE:ITGR) Trading Down 2.2% – Here’s What Happened

Integer Holdings Co. (NYSE:ITGR) fell 2.2% on Friday . The stock traded as low as $115.28 and last traded at $115.82. 456,285 shares changed hands during mid-day trading, an increase of 45% from the average session volume of 315,621 shares. The stock had previously closed at $118.40.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Benchmark upped their target price on shares of Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, February 21st. Citigroup increased their price target on shares of Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research report on Wednesday, December 11th. Wells Fargo & Company restated an “overweight” rating and issued a $160.00 target price on shares of Integer in a report on Tuesday, December 3rd. Oppenheimer cut Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Finally, KeyCorp increased their price objective on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $147.67.

Integer Stock Down 1.0 %

The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The company has a market cap of $3.94 billion, a PE ratio of 34.89, a PEG ratio of 1.72 and a beta of 1.24. The firm has a fifty day simple moving average of $134.43 and a 200 day simple moving average of $132.75.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 EPS for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The company had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Equities research analysts predict that Integer Holdings Co. will post 6.01 EPS for the current year.

Institutional Investors Weigh In On Integer

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Mather Group LLC. lifted its position in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 143 shares during the last quarter. Lee Danner & Bass Inc. acquired a new stake in shares of Integer during the fourth quarter worth $27,000. Huntington National Bank lifted its position in shares of Integer by 8,933.3% during the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock valued at $35,000 after acquiring an additional 268 shares during the period. R Squared Ltd bought a new position in shares of Integer during the 4th quarter worth about $44,000. Finally, Sterling Capital Management LLC increased its holdings in shares of Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider’s stock valued at $45,000 after acquiring an additional 279 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.